Hims & Hers shares drop 6% after FDA warning on semaglutide marketing claims
Hims & Hers Health Inc. (NYSE: HIMS) saw its stock fall 6% on Tuesday following ...
Apple could reap big gains from on-device AI, says Bernstein analyst
Apple Inc. (NASDAQ: AAPL) may emerge as one of the largest beneficiaries of on-device artificial ...
ARKK ETF stock: Is Cathie Wood’s flagship fund a buy today?
Cathie Wood’s Ark Innovation Fund (ARKK) stock price is doing well this year, and it ...
ULTY ETF is a 117% yielding fund, beating VOO: is it a buy?
The YieldMax Ultra Option Income Strategy ETF (ULTY) has done well this year and is ...
Should you invest in Lendbuzz IPO?
Boston-headquartered financial technology company, Lendbuzz, has officially filed for an initial public offering (IPO), targeting ...
Evening digest: Musk buys $1B Tesla shares, Google hits $3T, US China nears TikTok deal
Global markets and political circles witnessed a flurry of key developments on Monday evening, ranging ...
Here’s why the Gemini stock may crash soon after the IPO
Gemini stock price had a highly volatile first day as a publicly traded company. It ...
Here’s why the Opendoor stock short-squeeze is gaining steam
Opendoor stock price has gone parabolic this year, adding over $5.8 billion to its market ...
Top catalysts for Canada’s TSX Composite Index
Canadian stocks are firing on all cylinders this year, despite the headwinds brought by Donald ...
Top catalysts for Canada’s TSX Composite Index
Canadian stocks are firing on all cylinders this year, despite the headwinds brought by Donald ...